ID
41596
Beschrijving
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (IP Container) is to be filled out at Visit 2, 3, 4 and 5. Record the identifying number from the investigational product container dispensed at each visit. Record once at Visits 2 and 3 and twice at Visits 4 and 5.
Link
https://clinicaltrials.gov/ct2/show/NCT00784550
Trefwoorden
Versies (1)
- 19-11-20 19-11-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
19 november 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
IP Container
- StudyEvent: ODM
Beschrijving
IP Container
Alias
- UMLS CUI-1
- C3898691 (Investigational Medicinal Product Documentation)
- UMLS CUI-2
- C0180098 (Containers)
- SNOMED
- 706437002
Beschrijving
To be filled out once at visits 2 and 3 each and twice at visits 4 and 5.
Datatype
text
Alias
- UMLS CUI [1,1]
- C0304229 (Experimental drug)
- UMLS CUI [1,2]
- C0180098 (Containers)
- SNOMED
- 706437002
- UMLS CUI [1,3]
- C0600091 (Identifier)
- SNOMED
- 118522005
- LOINC
- LP31795-5
Similar models
IP Container
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
Geen commentaren